Phase II Pharmacokinetics Study of CAM2038
NCT02710526
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
INDUSTRY
Sponsor class
Conditions
Opioid Use Disorder
Chronic Pain
Interventions
DRUG:
CAM2038
Sponsor
Braeburn Pharmaceuticals